Skin Perfusion Pressure Testing Devices Market Analysis, Future Growth, Business Outlook, Size, Share, Development, Forecast to 2030

0

Future Market Insights (FMI), an ESOMAR-certified market research and consulting firm, offers insights into the key factors driving demand for skin perfusion pressure testing devices in a new study. The Skin Perfusion Pressure Testing Devices Market report analyzes the impact that COVID-19 has had on the medical device industry in general, and Skin Perfusion Pressure Testing Devices in particular.

The increasing prevalence of peripheral arterial disease and chronic limb ischemia has necessitated advances in skin perfusion pressure testing devices. Chronic limb ischemia is the most advanced form of peripheral arterial disease, resulting in mortality, morbidity, and intensive use of healthcare resources. The skin perfusion pressure method to check the blood flow pressure in the limbs is necessary to assess wound healing in limb ischemia.

Future Market Insights (FMI), an ESOMAR-certified market research and consulting firm, offers insights into the key factors driving demand for skin perfusion pressure testing devices in a new study. The Skin Perfusion Pressure Testing Devices Market report analyzes the impact that COVID-19 has had on the medical device industry in general, and Skin Perfusion Pressure Testing Devices in particular.

Get Sample PDF Brochure @
https://www.futuremarketinsights.com/reports/sample/rep-gb-9263

How to compare the historical and future outlook of the Skin Perfusion Pressure Testing Devices market?

Peripheral arterial disease (PAD) is a progressive disease that affects more than 200 million people worldwide. It has a significant impact on the mortality of hemodialysis patients. PAD affects approximately 6.5 million people in the United States age 40 and older. The increasing prevalence of PAD has fueled the growth of the skin perfusion pressure test market.

How is the shift to non-invasive procedures affecting sales of skin perfusion pressure testing devices?

Non-invasive procedures have continued to grow in popularity over surgeries. The measurement of cutaneous perfusion pressure by a laser doppler is a non-invasive method widely used by professionals. Due to its high reproducibility, accuracy, specificity and sensitivity, the skin perfusion pressure test has become one of the most reliable methods.

For example, the non-invasive instruments of the VMS-VASC (Moor) system, including the moorVMS-LDF Laser Doppler Monitor, Low Profile Fiber Optic Probe (VP-SPP), and the moorVMS-PRES Pressure Cuff Monitor have been specifically designed to aid vascular micro assessments in a variety of physiological research and clinical applications.

Country overviews

What is the opportunity in the United States?

The United States healthcare system is renowned for its infrastructure and advanced expenses. The care scheme of care centers and hospitals is controlled by various regulatory rules and insurance policies. Massive hospital bills incurred other than Medicare influenced the market in the country.

The United States government and regulators are adopting several cost containment plans to reduce their healthcare burden. The shift from a volume-based system to a value-based system is driven primarily by the various actions taken by vendors, governments, biotech companies and insurers. Some of these measures are outcome-based profits, pricing, risk sharing, tendering, and price controls.

A value-based healthcare system will not only deliver better outcomes through integrated care pathways, but will also put pressure on prices for medical device companies, which is likely to impact healthcare investments. R&D of advanced medical treatment technologies.

Additionally, due to the higher prevalence of critical limb ischemia and peripheral arterial disease in the United States, several manufacturers are conducting general awareness campaigns for people related to these diseases. This is expected to support the overall market growth in the country. For example, Amputee Coalition of America (NGO) launched a campaign in April 2018 to raise awareness about limb loss.

Why innovation is the key to success in the German medical device market?

The Federal Statistical Office reported that health spending in Germany increased by 4% in 2018 compared to 2017. In 2018, the country’s health spending accounted for 11.7% of GDP. Additionally, healthcare spending is expected to reach 407.4 billion euros by 2019, presenting a lucrative landscape for the expansion of skin perfusion pressure testing devices.

The presence of companies such as ELCAT GmbH also supports the expansion in Germany. The company has invested heavily in its expansion efforts. The growth strategies adopted by these companies should favor expansion in Germany.

Since 2009, health insurance has been compulsory for all citizens of the country. According to the National Center for Biotechnology Information (NCBI), a total of 70 million people, or about 85% of the population, are covered by statutory health insurance. Another 11% of the German population is covered by substitute private health insurance. Favorable reimbursement policies and a regulatory scenario present attractive growth opportunities.

How is rising disposable income in China affecting growth?

The increase in disposable income can have a significant impact on the development of the economy in emerging countries, which translates into the financial accessibility of appropriate health care. China’s per capita disposable income reached (about US$4,961) in 2020, more than double the 2010 level.

The potential for high health insurance and increased disposable income will help increase the accessibility of health services. It will also allow better accessibility to expensive equipment for the treatment of diseases. The Chinese market is expected to grow significantly with a CAGR of around 5.4%.

How can players increase the sales of Skin Perfusion Pressure Testing Devices in South Africa?

Chronic limb ischemia and peripheral arterial disease pose serious threats to the population. Lack of disease awareness and lack of proper treatment lead to high prevalence of these diseases. Due to a limited campaign on the assessment of these diseases, there appears to be less use of these devices in hospitals in South Africa.

Additionally, poor healthcare facilities in some countries are limiting the growth of the skin perfusion pressure testing market. Despite the financial burden, the South African government is adopting various initiatives to create awareness among the population, which is expected to lead to a steady growth of the market.

The market in South Africa is expected to grow slowly with a CAGR of around 3.8%.

Request report methodology@
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-9263

Competitive landscape

Most medical device companies are currently focusing on laser doppler design as it has gained popularity in wound healing assessment.

For example, Moor Instruments designed the moorVMS-VASC 2.0 laser doppler system.

Moreover, manufacturers are focusing on getting approvals for their product and securing partnership and collaboration agreements to expand their product portfolio in different countries around the world.

For example, in April 2016, Perimed AB announced FDA approval for PeriFlux 6000.

Some of the major companies operating in the market are:

  • Vasamed Incorporated
  • Moorish instruments
  • Expired AB
  • ELCAT GmbH
  • ATYS Medical
  • Viasonix
  • Promed Group

Skin Perfusion Pressure Testing Devices Market by Category

Product

  • Laser Doppler Skin Perfusion Pressure Test Devices
  • Devices for testing skin perfusion pressure by photoplethysmography
  • Consumables
    • Pressure cuff controller
    • fiber optic probe

Modality

  • portable devices
  • Trolley-mounted devices

Final user

  • Hospitals
  • Ambulatory surgery centers
  • Wound care centers
  • Vascular Laboratories

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Middle East and Africa (MEA)
  • Oceania

Ask Before You Buy @ Research Report
https://www.futuremarketinsights.com/askus/rep-gb-9263

According to IMF analysis, sales of skin perfusion pressure testing devices increased by 5.3% CAGR between 2015 and 2019.

Skin perfusion pressure has emerged as a potential tool for wound healing in patients with chronic limb ischemia. Compared to other non-invasive methods such as toe blood pressure and ankle-arm index, skin perfusion pressure provides more accurate results, thus, its use is gaining popularity among physicians.

This technique also remains a clinically relevant and objective tool for local perfusion in the setting of chronic limb ischemia, particularly in high-risk patients with arterial calicifications and comorbidities that tend towards microvascular disease. FMI expects the global market for skin perfusion pressure testing devices to grow at a CAGR of 4.5% through 2030.

Read related reports:

https://degentevakana.com/blogs/view/121254
https://vocal.media/stories/hypoparathyroidism-treatment-market-2022-scope-of-current-and-future-industry-2031
https://www.dronepilotlari.com/blogs/52528/Saudi-Arabia-Pharmaceutical-Market-2022-Key-Players-SWOT-Analysis-Key
https://vocal.media/stories/frontotemporal-disorders-treatment-market-2022-scope-of-current-and-future-industry-2028

About the IGF

Future Market Insights (ESOMAR certified market research organization and member of the Greater New York Chamber of Commerce) provides in-depth insights into the driving factors that increase demand in the market. It reveals opportunities that will drive market growth in various segments on the basis of source, application, sales channel, and end-use over the next 10 years.

Contact:

Future Market Outlook Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
Such. : +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/skin-perfusion-pressure-testing-devices-market
For sales inquiries: [email protected]
Browse the latest market reports:https://www.futuremarketinsights.com/reports
LinkedIn|Twitter|Blogs

Share.

Comments are closed.